Decreased activity and expression of these genes as a result of Aβ and tau has been described previously in AD (Amadio et al. 2009; Gong et al. 2006; Hartmann et al. 2019; Vitolo et al. 2002; Yin et al. 2016b). The gene discussed is MAPT; the disease is Alzheimer disease.